Pediatric cancer prediction has entered a new era with the integration of advanced AI technologies aimed at enhancing patient care and treatment outcomes.Recent studies reveal that innovative AI tools specifically designed for analyzing multiple brain scans over time can significantly outperform traditional methods in predicting relapse in pediatric cancer cases, particularly gliomas.